Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 33.36% is 32% above its 5-year average of 25.27%, near the high end of its 5-year range (-989.17%–376.14%).
19.65% above its 12-month average of 27.88%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 45.37%.
NET PROFIT MARGIN
33.36%
NET PROFIT MARGIN AVG TTM
27.88%
NET PROFIT MARGIN AVG 3Y
13.81%
NET PROFIT MARGIN AVG 5Y
25.27%
NET PROFIT MARGIN AVG 10Y
1.51%
NET PROFIT MARGIN AVG 15Y
-44.26%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+19.65%
CURRENT VS 3Y AVG
+141.49%
CURRENT VS 5Y AVG
+32.01%
CURRENT VS 10Y AVG
+2112.60%
CURRENT VS 15Y AVG
+175.37%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+9631.43%
vs the sector median at left
Ironwood Pharmaceuticals, Inc.
Market Cap
$597.55M
Net Profit Margin
33.36%
TTM Avg
27.88%
3Y Avg
13.81%
5Y Avg
25.27%
Market Cap
$596.01M
Net Profit Margin
-11.48%
TTM Avg
-11.55%
3Y Avg
-24.81%
5Y Avg
-19.75%
Market Cap
$584.48M
Net Profit Margin
-26.05%
TTM Avg
-16.91%
3Y Avg
-17.17%
5Y Avg
5.54%
Market Cap
$611.57M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$583.31M
Net Profit Margin
-15.72%
TTM Avg
-17.63%
3Y Avg
-12.08%
5Y Avg
-18.54%
Market Cap
$578.40M
Net Profit Margin
-144.63%
TTM Avg
-132.38%
3Y Avg
-98.61%
5Y Avg
-109.15%
Market Cap
$619.15M
Net Profit Margin
-93.86%
TTM Avg
-99.06%
3Y Avg
-127.16%
5Y Avg
-138.22%
Market Cap
$571.13M
Net Profit Margin
40.49%
TTM Avg
5.54%
3Y Avg
-11349.71%
5Y Avg
-11563.54%
Market Cap
$630.63M
Net Profit Margin
-115.18%
TTM Avg
-291.05%
3Y Avg
-192.01%
5Y Avg
-153.55%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals, Inc. (IRWD) | $597.55M | 33.36% | 27.88% | 13.81% | 25.27% |
| AngioDynamics, Inc. (ANGO)vs › | $596.01M | -11.48% | -11.55% | -24.81% | -19.75% |
| Fulgent Genetics, Inc. (FLGT)vs › | $584.48M | -26.05% | -16.91% | -17.17% | 5.54% |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | 0.00% | 0.00% | 0.00% | 0.00% |
| OrthoPediatrics Corp. (KIDS)vs › | $583.31M | -15.72% | -17.63% | -12.08% | -18.54% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $578.40M | -144.63% | -132.38% | -98.61% | -109.15% |
| SOPHiA GENETICS S.A. (SOPH)vs › | $619.15M | -93.86% | -99.06% | -127.16% | -138.22% |
| CorMedix Inc. (CRMD)vs › | $571.13M | 40.49% | 5.54% | -11349.71% | -11563.54% |
| OmniAb, Inc. (OABI)vs › | $630.63M | -115.18% | -291.05% | -192.01% | -153.55% |
| Prime Medicine, Inc. (PRME)vs › | $632.16M | -4613.11% | -5454.52% | -2727.26% | -1829.08% |
Operating Margin
40.1%
Net Profit Margin
33.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 45.37% |
| 2026-03-31 | 38.28% |
| 2025-12-31 | -4.77% |
| 2025-09-30 | 32.84% |
| 2025-06-30 | 27.69% |
| 2025-03-31 | -90.87% |
| 2024-12-31 | 2.49% |
| 2024-09-30 | 3.98% |
| 2024-06-30 | -0.91% |
| 2024-03-31 | -5.56% |
| 2023-12-31 | -0.92% |
| 2023-09-30 | 13.47% |
| 2023-06-30 | -989.17% |
| 2023-03-31 | 43.93% |
| 2022-12-31 | 45.59% |
| 2022-09-30 | 46.32% |
| 2022-06-30 | 38.14% |
| 2022-03-31 | 39.78% |
| 2021-12-31 | 35.32% |
| 2021-09-30 | 53.83% |
| 2021-06-30 | 376.14% |
| 2021-03-31 | 44.94% |
| 2020-12-31 | 37.03% |
| 2020-09-30 | 33.27% |
| 2020-06-30 | 28.18% |
| 2020-03-31 | 4.18% |
| 2019-12-31 | 37.89% |
| 2019-09-30 | 15.74% |
| 2019-06-30 | 12.02% |
| 2019-03-31 | -86.26% |
| 2018-12-31 | -11.85% |
| 2018-09-30 | -265.43% |
| 2018-06-30 | -60.88% |
| 2018-03-31 | -62.39% |
| 2017-12-31 | 12.83% |
| 2017-09-30 | -37.20% |
| 2017-06-30 | -67.96% |
| 2017-03-31 | -100.64% |
| 2016-12-31 | -15.44% |
| 2016-09-30 | -50.23% |
| 2016-06-30 | -39.93% |
| 2016-03-31 | -20.13% |
| 2015-12-31 | -26.33% |
| 2015-09-30 | -119.76% |
| 2015-06-30 | -173.08% |
| 2015-03-31 | -114.83% |
| 2014-12-31 | -98.88% |
| 2014-09-30 | -248.19% |
| 2014-06-30 | -882.41% |
| 2014-03-31 | -339.79% |
| 2013-12-31 | -1033.31% |
| 2013-09-30 | -1252.53% |
| 2013-06-30 | -674.21% |
| 2013-03-31 | -2884.85% |
| 2012-12-31 | -162.55% |
| 2012-09-30 | 49.41% |
| 2012-06-30 | -279.40% |
| 2012-03-31 | -290.67% |
| 2011-12-31 | -21.69% |
| 2011-09-30 | -168.87% |
| 2011-06-30 | -167.32% |
| 2011-03-31 | -179.75% |
| 2010-12-31 | -69.47% |
| 2010-09-30 | -91.29% |
| 2010-06-30 | -156.36% |
| 2010-03-31 | -175.92% |
| 2009-12-31 | -278.13% |
| 2009-09-30 | -71.46% |
| 2009-06-30 | -278.14% |
| 2009-03-31 | -343.49% |
| 2008-12-31 | -225.71% |
